Ectin Research AB
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
ECTIN B | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0015987706 (+1 more)
- LEI:
- 549300IDDKUG9RWXFN04
- Country:
- Sweden
- Address:
- c/o Walthon Advokater, 102 43 Stockholm
- Website:
- https://www.ectinresearch.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Ectin Research AB is a clinical-stage biotechnology company specializing in the research and development of novel cancer treatments. The company's lead drug candidate, MFA-370, is a therapeutic aimed at eliminating cancerous tumors. Initial development efforts and clinical trials are focused on the treatment of metastatic bladder cancer. The company is also actively expanding its preclinical portfolio to explore additional therapeutic applications for its technology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Ectin Research AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Ectin Research AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Ectin Research AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
